title: Histamine in the posterodorsal medial amygdala modulates cardiovascular reflex responses in awake rats.
abstract: Centrally injected histamine (HA) affects heart rate (HR), arterial blood pressure (BP), and sympathetic activity in rats. The posterodorsal medial amygdala (MePD) has high levels of histidine decarboxylase, connections with brain areas involved with the modulation of cardiovascular responses, and is relevant for the pathogenesis of hypertension. However, there is no report demonstrating the role of the MePD histaminergic activity on the cardiovascular function in awake rats. The aims of the present work were: 1) to study the effects of two doses (10-100 nM) of HA microinjected in the MePD on basal cardiovascular recordings and on baroreflex- and chemoreflex-mediated responses; 2) to reveal whether cardiovascular reflex responses could be affected by MePD microinjections of (R)-alpha-methylhistamine (AH3), an agonist of the inhibitory autoreceptor H3; and, 3) to carry out a power spectral analysis to evaluate the contribution of the sympathetic and parasympathetic components in the variability of the HR and BP recordings. When compared with the control group (microinjected with saline, 0.3 microl), HA (10 nM) promoted an increase in the MAP50, i.e. the mean value of BP at half of the HR range evoked by the baroreflex response. Histamine (100 nM) did not affect the baroreflex activity, but significantly decreased the parasympathetic component of the HR variability, increased the sympathetic/parasympathetic balance at basal conditions (these two latter evaluated by the power spectral analysis), and promoted an impairment in the chemoreflex bradycardic response. Microinjection of AH3 (10 microM) led to mixed results, which resembled the effects of both doses of HA employed here. Present data suggest that cardiovascular changes induced by baroreceptors and chemoreceptors involve the histaminergic activity in the MePD. This neural regulation of reflex cardiovascular responses can have important implications for homeostatic and allostatic conditions and possibly for the behavioral displays modulated by the rat MePD.
authors.affiliation: Department of Physiological Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre, R. Sarmento Leite 245, Porto Alegre 90170-050 RS, Brazil.
authors.forename: E
authors.initials: E
authors.lastname: Quagliotto
authors.forename: H
authors.initials: H
authors.lastname: Neckel
authors.forename: D F
authors.initials: DF
authors.lastname: Riveiro
authors.forename: K R
authors.initials: KR
authors.lastname: Casali
authors.forename: C
authors.initials: C
authors.lastname: Mostarda
authors.forename: M C
authors.initials: MC
authors.lastname: Irigoyen
authors.forename: P
authors.initials: P
authors.lastname: Dall'ago
authors.forename: A A
authors.initials: AA
authors.lastname: Rasia-Filho
mesh_terms: D000679:Amygdala / Q000187:drug effects*; D000704:Analysis of Variance; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D006339:Heart Rate / Q000187:drug effects*; D006439:Hemodynamics / Q000187:drug effects; D006632:Histamine / Q000494:pharmacology*; D017442:Histamine Agonists / Q000494:pharmacology*; D008297:Male; D008761:Methylhistamines / Q000494:pharmacology; D008845:Microinjections / Q000379:methods; D051381:Rats; D017208:Rats, Wistar; D013057:Spectrum Analysis; D014851:Wakefulness
chemical_list: D017442:Histamine Agonists; D008761:Methylhistamines; C069357:alpha-methylhistamine; D006632:Histamine